ANALYSIS OF TRENDS IN THE PERFORMANCE OF URINARY DIVERSIONS AFTER TOTAL CYSTECTOMY: A 15-YEAR EXPERIENCE
Abstract
The aim of our study was to analyse trends in urinary diversion (UD) in patients who underwent radical cystectomy (RC) from 2008 to 2023, with special reference to the period of the COVID-19 pandemic. A total of 283 study patients (pts) (243 men and 40 women, mean age 65.07 ± 7.73 years) were divided by the type of UD into the following groups: Mainz-pouch II (MP II) – 85 pts, ileal conduit (IC) – 89 pts, ureterocutaneostomy (UCS) – 105 pts, percutaneous nephrostomy (PCN) – 4 pts. The relative share of incontinent and continent UD was 70% and 30%, respectively. MP II was the most represented UD from 2008 to 2013, IC from 2014 to 2019, and UCS from 2019 to 2023. The most common UD was UCS (37.1%), followed by IC (31.4%), MP II (30.0%) and PCN (1.4%). Temporal UD trends were variable, with relatively stable annual shares of MP II and IC and the lowest annual share of UCS until the period of the COVID-19 pandemic, when it significantly increased, with a peak in 2022. Trend analysis shows a significant increase of UCSs in the period 2008−2023 (p < 0.001), without significant change of trends in the other groups (p > 0.05). The trends of continent and incontinent UD after RC, shown in our study, are consistent with the data reported in the current literature.
References
Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, et al. International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol 2013;63(1):16-35. [CrossRef] [PubMed]
Basic DT, Hadzi-Djokic J, Ignjatovic I. The history of urinary diversion. Acta Chir Iugosl 2007;54(4):9-17. [CrossRef] [PubMed]
Basić DT, Studer UE. Selection and perioperative management of patients undergoing an orthotopic ileal bladder substitution. Acta Chir Iugosl 2005;52(3):25-31. [CrossRef] [PubMed]
Bašić DT. Istorijat urinarnih derivacija. Ileumski konduit. In: Jovan Hadži-Đokić, editor. Urinarne derivacije. Beograd: Elit Medica. 2009; 8-9.
Cerruto MA, D'Elia C, Siracusano S, Gedeshi X, Mariotto A, Iafrate M, et al. Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. Eur J Surg Oncol 2016;42(3):343-60. [CrossRef] [PubMed]
Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 2017;198(3):552-9. [CrossRef] [PubMed]
Cohn JA, Large MC, Richards KA, Steinberg GD, Bales GT. Cystectomy and urinary diversion as management of treatment-refractory benign disease: The impact of preoperative urological conditions on perioperative outcomes. Int J Urol 2013;21:382-6. [CrossRef] [PubMed]
Compérat E, Amin MB, Berney DM, Cree I, Menon S, Moch H, et al. What's new in WHO fifth edition - urinary tract. Histopathology 2022;81(4):439-46. [CrossRef] [PubMed]
COVIDSurg Collaborative. Global guidance for surgical care during the COVID-19 pandemic. Br J Surg 2020;107(9):1097-103. [CrossRef] [PubMed]
Deliveliotis C, Papatsoris A, Chrisofos M, Dellis A, Liakouras C, Skolarikos A. Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit? Urology 2005;66(2):299-304. [CrossRef] [PubMed]
Farber NJ, Faiena I, Dombrovskiy V, Tabakin AL, Shinder B, Patel R, et al. Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer. Bladder Cancer 2018;4(1):113-20. [CrossRef] [PubMed]
Fisch M, Wammack R, Müller SC, Hohenfellner R. The Mainz pouch II (sigma rectum pouch). J Urol 1993;149(2):258-63. [CrossRef] [PubMed]
Gore JL, Yu HY, Setodji C, Hanley JM, Litwin MS, Saigal CS; Urologic Diseases in America Project. Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer 2010;116(2):331-9. [CrossRef] [PubMed]
Hadzi-Djokic JB, Basic DT. A modified sigma-rectum pouch (Mainz pouch II) technique: analysis of outcomes and complications on 220 patients. BJU Int 2006;97(3):587-91. [CrossRef] [PubMed]
Ignjatovic I, Basic D. Modified Mainz pouch II (Sigma Rectum pouch) urinary diversion: 12 years experience. Acta Chir Iugosl 2007;54(4):73-7. [CrossRef] [PubMed]
Katims AB, Razdan S, Eilender BM, Wiklund P, Tewari AK, Kyprianou N et al. Urologic oncology practice during COVID-19 pandemic: a systematic review on what can be deferrable vs. nondeferrable. Urol Oncol 2020;38(10):783-92. [CrossRef] [PubMed]
Korkes F, Fernandes E, Gushiken FA, Glina FPA, Baccaglini W, Timóteo F, Glina S. Bricker ileal conduit vs. Cutaneous ureterostomy after radical cystectomy for bladder cancer: a systematic review. Int Braz J Urol 2022;48(1):18-30. [CrossRef] [PubMed]
Kozacıoğlu Z, Değirmenci T, Günlüsoy B, Ceylan Y, Minareci S. Ureterocutaneostomy: for whom and when? Turk J Urol 2013;39(3):143-6. [CrossRef] [PubMed]
Lin-Brande M, Nazemi A, Pearce SM, Thompson ER, Ashrafi AN, Djaladat H, et al. Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States. Urol Oncol 2019;37(3):180.e1-180.e9. [CrossRef] [PubMed]
Linn JF, Hohenfellner M, Roth S, Dahms SE, Stein R, Hertle L, et al. Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J Urol 1998;159:774-8. [CrossRef] [PubMed]
Lowrance WT, Rumohr JA, Clark PE, Chang SS, Smith JA Jr, Cookson MS. Urinary diversion trends at a high volume, single American tertiary care center. J Urol 2009;182(5):2369-74. [CrossRef] [PubMed]
Moeen AM, Safwat AS, Gadelmoula MM, Moeen SM, Abonnoor AEI, Abbas WM, et al. Health related quality of life after urinary diversion. Which technique is better? J Egypt Natl Canc Inst 2018;30(3):93-7. [CrossRef] [PubMed]
Nabil RA, Warli SM, Siregar GP, Prapiska FF. Comparison of long-term outcomes between ileal conduit and transuretero-cutaneostomy urinary diversion after radical cystectomy: a systematic review and meta-analysis. Rep Pract Oncol Radiother 2024;29(1):103-12. [CrossRef] [PubMed]
Neulander EZ, Rivera I, Eisenbrown N, Wajsman Z. Simple cystectomy in patients requiring urinary diversion. J Urol 2000;164: 1169-72. [CrossRef] [PubMed]
Osborn DJ, Dmochowski RR, Kaufman MR, Milam DF, Mock S, Reynolds WS. Cystectomy with urinary diversion for benign disease: indications and outcomes. Urology 2014;83(6):1433-7. [CrossRef] [PubMed]
Peeker R, Aldenborg F, Fall M. The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol 1998;159: 1479-82. [CrossRef] [PubMed]
Pycha A, Comploj E, Martini T, Trenti E, Mian C, Lusuardi L, et al. Comparison of complications in three incontinent urinary diversions. Eur Urol 2008;54:825-32. [CrossRef] [PubMed]
Rezaee ME, Atwater BL, Bihrle W, Schroeck FR, Seigne JD. Ileal Conduit Versus Continent Urinary Diversion in Radical Cystectomy: A Retrospective Cohort Study of 30-day Complications, Readmissions, and Mortality. Urology 2022;170:139-45. [CrossRef] [PubMed]
Rowley MW, Clemens JQ, Latini JM, Cameron AP. Simple cystectomy: outcomes of a new operative technique. Urology 2011;78:942-5. [CrossRef] [PubMed]
Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Med Sci (Basel) 2020;8(1):15. [CrossRef] [PubMed]
Skinner EC. Choosing the right urinary diversion: Patient’s choice or surgeon’s inclination? Urol Oncol 2011;29(5): 473-5. [CrossRef] [PubMed]
Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto JWF, Canes D. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020;77(6):663-6. [CrossRef] [PubMed]
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209-49. [CrossRef] [PubMed]
WHO Classification of Tumours - Urinary and Male Genital Tumours, 2022. IARC, Lyon, France https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Urinary-And- Male-Genital-Tumours-2022
Witjes JA, Bruins HM, Carrión A, Cathomas R, Compérat EM, Efstathiou JA, et al. Epidemiology, aetiology and pathology. In: EAU Guidelines on muscle-invasive and metastatic bladder cancer (Witjes JA, et al, eds). EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023:8-12. EAU Guidelines Office, Arnhem, The Netherlands.
